Literature DB >> 24654588

Epidemiology of neuropathic pain.

Blair H Smith1, Nicola Torrance.   

Abstract

Epidemiology is an essential clinical tool in designing and evaluating management and prevention strategies, and is particularly relevant to neuropathic pain. Despite its relevance to neuropathic pain however, there is a paucity of accurate information on its prevalence, distribution and determinants, for several reasons. In many ways, it is appropriate to study neuropathic pain merely as a symptom or a pain mechanism rather than a specific disease. However, the different causes display sufficient similarities in their clinical and personal impact, and in their response to treatment, to make it worthwhile to consider neuropathic pain as a distinct condition. There are, however, important specific disease-based factors that need to be considered separately. Older estimates of the prevalence of neuropathic pain (based on specific diagnoses) tend to be lower (1-2%) than newer estimates that are based on questionnaires examining classic symptoms (6-8%). Further methodological research is needed to clarify these. Associated poor general health is a feature of all neuropathic pain, similar to other severe chronic diseases.

Entities:  

Year:  2011        PMID: 24654588     DOI: 10.2217/pmt.10.5

Source DB:  PubMed          Journal:  Pain Manag        ISSN: 1758-1869


  7 in total

Review 1.  Epidemiology of neuropathic pain and its impact on quality of life.

Authors:  Blair H Smith; Nicola Torrance
Journal:  Curr Pain Headache Rep       Date:  2012-06

2.  Towards a definition of refractory neuropathic pain for epidemiological research. An international Delphi survey of experts.

Authors:  Blair H Smith; Nicola Torrance; Janice A Ferguson; Michael I Bennett; Michael G Serpell; Kate M Dunn
Journal:  BMC Neurol       Date:  2012-05-28       Impact factor: 2.474

3.  Treatment of localized neuropathic pain after disk herniation with 5% lidocaine medicated plaster.

Authors:  Rudolf Likar; Ingo Kager; Michael Obmann; Wolfgang Pipam; Reinhard Sittl
Journal:  Int J Gen Med       Date:  2012-08-17

Review 4.  G-Protein Coupled Receptors Targeted by Analgesic Venom Peptides.

Authors:  James T Daniel; Richard J Clark
Journal:  Toxins (Basel)       Date:  2017-11-16       Impact factor: 4.546

Review 5.  A Review of Scientific Evidence for THC:CBD Oromucosal Spray (Nabiximols) in the Management of Chronic Pain.

Authors:  Michael A Überall
Journal:  J Pain Res       Date:  2020-02-14       Impact factor: 3.133

6.  Can treatment success with 5% lidocaine medicated plaster be predicted in cancer pain with neuropathic components or trigeminal neuropathic pain?

Authors:  Kai-Uwe Kern; Srinivas Nalamachu; Louis Brasseur; Joanna M Zakrzewska
Journal:  J Pain Res       Date:  2013-04-05       Impact factor: 3.133

7.  Trends in long-term opioid prescribing in primary care patients with musculoskeletal conditions: an observational database study.

Authors:  John Bedson; Ying Chen; Richard A Hayward; Julie Ashworth; Kate Walters; Kate M Dunn; Kelvin P Jordan
Journal:  Pain       Date:  2016-07       Impact factor: 7.926

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.